Abstract
Seemingly contrasting genetic backgrounds in anti-citrullinated-protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) support the notion that these are in fact two distinct disease subsets, with different underlying pathogenesis, that might need tailored treatment strategies.
Publication types
-
News
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Arthritis, Rheumatoid / classification
-
Arthritis, Rheumatoid / genetics*
-
Arthritis, Rheumatoid / immunology
-
Autoantibodies / genetics*
-
Genetic Association Studies
-
Genetic Predisposition to Disease*
-
Genetic Variation
-
Humans
-
Peptides, Cyclic / immunology*
-
Treatment Outcome
Substances
-
Autoantibodies
-
Peptides, Cyclic
-
cyclic citrullinated peptide